Cancer and Pregnancy in the Post-Roe v. Wade Era: A Comprehensive Review

Autor: Ganguly Arup, Narmala Shravan

Publikováno v: Current Oncology, Vol 30, Iss 11, Pp 9448-9457 (2023)

Cancer during pregnancy, affecting 1 in 1000 pregnancies, is rising in incidence due to delayed childbearing and improved detection. Common types include breast cancer, melanoma and cervical cancer and Hodgkin’s Lymphoma. There are several physiolo

Externí odkaz: https://doaj.org/article/320b24f203f442328d062fa334aae7d8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers.

Autor: Khuc TA; Medicine, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA., Pequeno G; Medicine, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA., Betancourt-Garcia M; Center of Excellence for Trauma Research in the Border Region, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA., Casciato AM; Medicine, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA., Gomez-Martinez M; Family Medicine, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA., Arroyo CD; Medicine, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA., Pope BD 3rd; Medicine, University of Texas Rio Grande Valley School of Medicine, Edinburg, USA., Narmala S; Hematology and Oncology, Doctor's Hospital Renaissance (DHR) Health, Edinburg, USA., Rao S; Medicine, Doctor's Hospital Renaissance (DHR) Health Institute for Research and Development, Edinburg, USA.

Publikováno v: Cureus [Cureus] 2023 Jul 11; Vol. 15 (7), pp. e41696. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023).

Breakthrough medicines during the COVID-19 pandemic era.

Autor: Ghali ENHK; Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA.; South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA., Dhevan V; Department of Surgery, University of Texas Rio Grande Valley, Harlingen, TX 78550, USA., K Narmala S; DHR Health Hematology Oncology Institute, DHR Health, Edinburg, TX 78539, USA., Jaggi M; Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA.; South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA., C Chauhan S; Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA.; South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA., M Yallapu M; Department of Immunology & Microbiology, School of Medicine, The University of Texas Rio Grande Valley, McAllen, TX 78504, USA.; South Texas Center of Excellence in Cancer Research, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA.

Publikováno v: Future drug discovery [Future Drug Discov] 2022 Jan; Vol. 4 (1), pp. FDD69. Date of Electronic Publication: 2022 Feb 08.

A 28-year-old man with leukocytosis and anemia.

Autor: Narmala SK; LSUHSC, New Orleans, USA., Gandla KK, Verghese C, Bourgeois K, Boulmay BC

Publikováno v: The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society [J La State Med Soc] 2010 Jan-Feb; Vol. 162 (1), pp. 8-13.